Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma-Reference-Cited by-同舟云学术

Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma

Published:2022-07-09 Issue:1 Volume:23 Page:417-423
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Hsu Andrew¹,Huntington Kelsey E.²³,De Souza Andre¹²,Zhou Lanlan²³,Olszewski Adam J.¹²,Makwana Nirav P.⁴,Treaba Diana O.³,Cavalcante Ludimila⁵,Giles Francis J.⁵,Safran Howard¹²,El-Deiry Wafik S.¹²³,Carneiro Benedito A.¹²^ORCID

Affiliation:

1. Division of Hematology/Oncology, Brown University and the Lifespan Cancer Institute, Providence, RI, USA

2. Legorreta Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Providence, RI, USA

3. Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA

4. Department of Radiology, The Warren Alpert Medical School, Brown University, Providence, RI, USA

5. Actuate Therapeutics, Fort Worth, Tx, USA

Funder

This work was supported by the Teymour Alireza P’98, P’00 Family Cancer Research Fund established by the Alireza Family

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2022.2088984

Reference39 articles.

1. Global epidemiology of HTLV-I infection and associated diseases

2. Treatment and survival among 1594 patients with ATL

3. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma.

4. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers

5. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Strategy for Adult T‐Cell Leukemia Treatment Targeting Glycogen Synthase Kinase‐3β;European Journal of Haematology;2024-09-06

2. Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin;International Journal of Molecular Sciences;2024-08-07

3. Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner;Life Sciences;2024-08

4. Elraglusib induces cytotoxicity via direct microtubule destabilisation independently of GSK3 inhibition;2024-07-08

5. Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer;Frontiers in Immunology;2024-05-15